Literature DB >> 7883987

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

D J Rader1, W A Mann, W Cain, H G Kraft, D Usher, L A Zech, J M Hoeg, J Davignon, P Lupien, M Grossman.   

Abstract

Lipoprotein(a) [Lp(a)] is an atherogenic lipoprotein which is similar in structure to low density lipoproteins (LDL). The role of the LDL receptor in the catabolism of Lp(a) has been controversial. We therefore investigated the in vivo catabolism of Lp(a) and LDL in five unrelated patients with homozygous familial hypercholesterolemia (FH) who have little or no LDL receptor activity. Purified 125I-Lp(a) and 131I-LDL were simultaneously injected into the homozygous FH patients, their heterozygous FH parents when available, and control subjects. The disappearance of plasma radioactivity was followed over time. As expected, the fractional catabolic rates (FCR) of 131I-LDL were markedly decreased in the homozygous FH patients (mean LDL FCR 0.190 d-1) and somewhat decreased in the heterozygous FH parents (mean LDL FCR 0.294 d-1) compared with controls (mean LDL FCR 0.401 d-1). In contrast, the catabolism of 125I-Lp(a) was not significantly different in the homozygous FH patients (mean FCR 0.251 d-1), heterozygous FH parents (mean FCR 0.254 d-1), and control subjects (mean FCR 0.287 d-1). In summary, absence of a functional LDL receptor does not result in delayed catabolism of Lp(a), indicating that the LDL receptor is not a physiologically important route of Lp(a) catabolism in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883987      PMCID: PMC441483          DOI: 10.1172/JCI117794

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies.

Authors:  M Bojanovski; R E Gregg; D M Wilson; H B Brewer
Journal:  Clin Chim Acta       Date:  1987-12       Impact factor: 3.786

2.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

Authors:  G Utermann; H J Menzel; H G Kraft; H C Duba; H G Kemmler; C Seitz
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.

Authors:  J Thiery; V W Armstrong; J Schleef; C Creutzfeldt; W Creutzfeldt; D Seidel
Journal:  Klin Wochenschr       Date:  1988-05-16

4.  Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts.

Authors:  L Havekes; B J Vermeer; T Brugman; J Emeis
Journal:  FEBS Lett       Date:  1981-09-28       Impact factor: 4.124

5.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Authors:  D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Isolation of apolipoprotein(a) from lipoprotein(a).

Authors:  G M Fless; M E ZumMallen; A M Scanu
Journal:  J Lipid Res       Date:  1985-10       Impact factor: 5.922

7.  Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; A Roscher; F Haslauer; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.

Authors:  B Vessby; G Kostner; H Lithell; J Thomis
Journal:  Atherosclerosis       Date:  1982-07       Impact factor: 5.162

9.  Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects.

Authors:  B L Knight; Y F Perombelon; A K Soutar; D P Wade; M Seed
Journal:  Atherosclerosis       Date:  1991-04       Impact factor: 5.162

10.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

Authors:  V W Armstrong; P Cremer; E Eberle; A Manke; F Schulze; H Wieland; H Kreuzer; D Seidel
Journal:  Atherosclerosis       Date:  1986-12       Impact factor: 5.162

View more
  38 in total

1.  Lipoprotein (a) metabolism estimated by nonsteady-state kinetics.

Authors:  K G Parhofer; T Demant; M M Ritter; H C Geiss; M Donner; P Schwandt
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

Review 2.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

3.  HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).

Authors:  Calvin Yeang; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2015-05-26       Impact factor: 5.922

4.  Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.

Authors:  Patrick M Moriarty; Stephen A Varvel; Philip L S M Gordts; Joseph P McConnell; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-05       Impact factor: 8.311

Review 5.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 6.  PCSK9: From Basic Science Discoveries to Clinical Trials.

Authors:  Michael D Shapiro; Hagai Tavori; Sergio Fazio
Journal:  Circ Res       Date:  2018-05-11       Impact factor: 17.367

7.  Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.

Authors:  N W Boonmark; X J Lou; Z J Yang; K Schwartz; J L Zhang; E M Rubin; R M Lawn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

8.  Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia.

Authors:  E Meriño-Ibarra; J Puzo; E Jarauta; A Cenarro; D Recalde; A L García-Otín; E Ros; E Martorell; X Pintó; M Franco; D Zambón; A Brea; M Pocoví; F Civeira
Journal:  J Inherit Metab Dis       Date:  2007-10-20       Impact factor: 4.982

9.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

10.  PCSK9 Association With Lipoprotein(a).

Authors:  Hagai Tavori; Devon Christian; Jessica Minnier; Deanna Plubell; Michael D Shapiro; Calvin Yeang; Ilaria Giunzioni; Mikael Croyal; P Barton Duell; Gilles Lambert; Sotirios Tsimikas; Sergio Fazio
Journal:  Circ Res       Date:  2016-04-27       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.